(C) Relative mRNA expression of E-cad (Exo-3B, no CC, P = 0.0266; CC, P = 0.0491; Exo-3B-KD, no CC, P = 0.0473; CC, P = 0.1337), Slug (Exo-3B, P = 0.0069, P = 0.0019; Exo-3B-KD, P = 0.0040, P = 0.0016) and ZO-1 (Exo-3B, P < 0.0001, P = 0.0016; Exo-3B-KD, P = 0.0008, P = 0.9323) in tumor cells treated with Compound C (CC, a drug to inhibit phosphorylation of AMPK) and EXO-3B or Exo-3B-KD. This evidence concerns the gene TJP1 and neoplasm.